EGFR signaling blunts allergen-induced IL-6 production and th17 responses in the skin and attenuates development and relapse of atopic dermatitis

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 859-866

  Zhang, Zhonghua ^a   Xiao, Chang ^a   Gibson, Aaron M ^a   Bass, Stacey A ^a   Hershey, Gurjit K Khurana ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; DISEASE EXACERBATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LYMPH NODE CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN ALLERGY; SKINFOLD THICKNESS;

ADMINISTRATION, CUTANEOUS; ALLERGENS; ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOKINE CXCL2; DERMATITIS, ATOPIC; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKINS; KERATINOCYTES; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECURRENCE; SIGNAL TRANSDUCTION; SKIN; SPECIFIC PATHOGEN-FREE ORGANISMS; TH17 CELLS;

EID: 84893414859     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301062     Document Type: Article

References (58)

1. Bieber, T. 2010. Atopic dermatitis. Ann Dermatol 22: 125-137.
2. Odhiambo, J. A., H. C. Williams, T. O. Clayton, C. F. Robertson, and M. I. Asher. 2009. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J. Allergy Clin. Immunol. 124: 1251-1258 e1223.
3. Bos, J. D., M. E. Schram, and J. R. Mekkes. 2009. Dermatologists are essential for quality of care in the general practice of medicine. Actas Dermosifiliogr. 100 (Suppl 1): 101-105.
4. Boguniewicz, M., and D. Y. Leung. 2011. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 242: 233-246.
5. De Benedetto, A., N. M. Rafaels, L. Y. McGirt, A. I. Ivanov, S. N. Georas, C. Cheadle, A. E. Berger, K. Zhang, S. Vidyasagar, T. Yoshida, M. Boguniewicz, T. Hata, L. C. Schneider, J. M. Hanifin, R. L. Gallo, N. Novak, S. Weidinger, T. H. Beaty, D. Y. Leung, K. C. Barnes, and L. A. Beck. 2011. Tight junction defects in patients with atopic dermatitis. J. Allergy Clin. Immunol. 127: 773-786 e771-777.
6. Werfel, T. 2009. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 129: 1878-1891.
7. Brandt, E. B., and U. Sivaprasad. 2011. Th2 Cytokines and Atopic Dermatitis. J. Clin. Cell Immunol. 2(3
8. Dokmeci, E., and C. A. Herrick. 2008. The immune system and atopic dermatitis. Semin. Cutan. Med. Surg. 27: 138-143.
9. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
10. Lipozencić, J., Z. Pastar, S. M. Kulisić, and I. Pavić. 2009. Immunologic aspects of atopic dermatitis. Acta Dermatovenerol. Croat. 17: 226-234.
11. Spergel, J. M., E. Mizoguchi, J. P. Brewer, T. R. Martin, A. K. Bhan, and R. S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101: 1614-1622.
12. Spergel, J. M., E. Mizoguchi, H. Oettgen, A. K. Bhan, and R. S. Geha. 1999. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103: 1103-1111.
13. Koga, C., K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura. 2008. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128: 2625-2630.
14. He, R., H. Y. Kim, J. Yoon, M. K. Oyoshi, A. MacGinnitie, S. Goya, E. J. Freyschmidt, P. Bryce, A. N. McKenzie, D. T. Umetsu, H. C. Oettgen, and R. S. Geha. 2009. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J. Allergy Clin. Immunol. 124: 761-770 e761.
15. He, R., M. K. Oyoshi, H. Jin, and R. S. Geha. 2007. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. USA 104: 15817-15822.
16. Oyoshi, M. K., G. F. Murphy, and R. S. Geha. 2009. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 124: 485-493, 493 e481.
17. Egger, B., M. W. Buchler, J. Lakshmanan, P. Moore, and V. E. Eysselein. 2000. Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis. Scand. J. Gastroenterol. 35: 1181-1187.
18. Egger, B., H. V. Carey, F. Procaccino, N. N. Chai, E. P. Sandgren, J. Lakshmanan, V. S. Buslon, S. W. French, M. W. Buchler, and V. E. Eysselein. 1998. Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut 43: 64-70.
19. Troyer, K. L., N. C. Luetteke, M. L. Saxon, T. H. Qiu, C. J. Xian, and D. C. Lee. 2001. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-Alpha. Gastroenterology 121: 68-78.
20. Berlanga-Acosta, J., J. Gavilondo-Cowley, P. López-Saura, T. González-López, M. D. Castro-Santana, E. López-Mola, G. Guillén-Nieto, and L. Herrera-Martinez. 2009. Epidermal growth factor in clinical practice -A review of its biological actions, clinical indications and safety implications. Int. Wound J. 6: 331-346.
21. Repertinger, S. K., E. Campagnaro, J. Fuhrman, T. El-Abaseri, S. H. Yuspa, and L. A. Hansen. 2004. EGFR enhances early healing after cutaneous incisional wounding. J. Invest. Dermatol. 123: 982-989.
22. Werner, S., and R. Grose. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83: 835-870.
23. Pastore, S., and F. Mascia. 2008. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol 3: 525-527.
24. Pastore, S., F. Mascia, V. Mariani, and G. Girolomoni. 2008. The epidermal growth factor receptor system in skin repair and inflammation. J. Invest. Dermatol. 128: 1365-1374.
25. Cook, P. W., J. R. Brown, K. A. Cornell, and M. R. Pittelkow. 2004. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp. Dermatol. 13: 347-356.
26. Cook, P.W., M. Piepkorn, C. H. Clegg, G. D. Plowman, J. M. DeMay, J. R. Brown, and M. R. Pittelkow. 1997. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 100: 2286-2294.
27. Zaiss, D. M., J. van Loosdregt, A. Gorlani, C. P. Bekker, A. Grone, M. Sibilia, P. M. van Bergen en Henegouwen, R. C. Roovers, P. J. Coffer, and A. J. Sijts. 2013. Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 38: 275-284.
28. Dominey, A. M., X. J. Wang, L. E. King, Jr., L. B. Nanney, T. A. Gagne, K. Sellheyer, D. S. Bundman, M. A. Longley, J. A. Rothnagel, D. A. Greenhalgh, et al. 1993. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ. 4: 1071-1082.
29. Vassar, R., and E. Fuchs. 1991. Transgenic mice provide new insights into the role of TGF-Alpha during epidermal development and differentiation. Genes Dev. 5: 714-727.
30. Shirasawa, S., S. Sugiyama, I. Baba, J. Inokuchi, S. Sekine, K. Ogino, Y. Kawamura, T. Dohi, M. Fujimoto, and T. Sasazuki. 2004. Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc. Natl. Acad. Sci. USA 101: 13921-13926.
31. Mascia, F., V. Mariani, G. Girolomoni, and S. Pastore. 2003. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am. J. Pathol. 163: 303-312.
32. Pastore, S., F. Mascia, and G. Girolomoni. 2006. The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur. J. Dermatol. 16: 125-131.
33. Yamaki, M., K. Sugiura, Y. Muro, Y. Shimoyama, and Y. Tomita. 2010. Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes. Exp. Dermatol. 19: 730-735.
34. Luetteke, N. C., T. H. Qiu, S. E. Fenton, K. L. Troyer, R. F. Riedel, A. Chang, and D. C. Lee. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
35. Sivaprasad, U., M. R. Warrier, A. M. Gibson, W. Chen, Y. Tabata, S. A. Bass, M. E. Rothenberg, and G. K. Khurana Hershey. 2010. IL-13Ra2 has a protective role in a mouse model of cutaneous inflammation. J. Immunol. 185: 6802-6808.
36. Wise-Draper, T. M., R. J. Morreale, T. A. Morris, R. A. Mintz-Cole, E. E. Hoskins, S. J. Balsitis, N. Husseinzadeh, D. P. Witte, K. A. Wikenheiser-Brokamp, P. F. Lambert, and S. I. Wells. 2009. DEK proto-oncogene expression interferes with the normal epithelial differentiation program. Am. J. Pathol. 174: 71-81.
37. Le Cras, T. D., T. H. Acciani, E. M. Mushaben, E. L. Kramer, P. A. Pastura, W. D. Hardie, T. R. Korfhagen, U. Sivaprasad, M. Ericksen, A. M. Gibson, et al. 2011. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L414-L421.
38. Luetteke, N. C., H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8: 399-413.
39. Hegymegi-Barakonyi, B., D. Eros, C. Szántai-Kis, N. Breza, P. Bánhegyi, G. V. Szabó, E. Várkondi, I. Peták, L. Orfi, and G. Kéri. 2009. Tyrosine kinase inhibitors -small molecular weight compounds inhibiting EGFR. Curr. Opin. Mol. Ther. 11: 308-321.
40. Peus, D., L. Hamacher, and M. R. Pittelkow. 1997. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J. Invest. Dermatol. 109: 751-756.
41. Stoll, S., W. Garner, and J. Elder. 1997. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. J. Clin. Invest. 100: 1271-1281.
42. Stoll, S. W., M. Benedict, R. Mitra, A. Hiniker, J. T. Elder, and G. Nunez. 1998. EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL. Oncogene 16: 1493-1499.
43. Guttman-Yassky, E., K. E. Nograles, and J. G. Krueger. 2011. Contrasting pathogenesis of atopic dermatitis and psoriasis -part II: immune cell subsets and therapeutic concepts. J. Allergy Clin. Immunol. 127: 1420-1432.
44. Ghoreschi, K., A. Laurence, X. P. Yang, C. M. Tato, M. J. McGeachy, J. E. Konkel, H. L. Ramos, L. Wei, T. S. Davidson, N. Bouladoux, et al. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-b signalling. Nature 467: 967-971.
45. Wang, Y. H., and M. Wills-Karp. 2011. The potential role of interleukin-17 in severe asthma. Curr. Allergy Asthma Rep. 11: 388-394.
46. Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
47. Reynolds, J. M., P. Angkasekwinai, and C. Dong. 2010. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 21: 413-423.
48. Johnston, A., J. E. Gudjonsson, A. Aphale, A. M. Guzman, S. W. Stoll, and J. T. Elder. 2011. EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. J. Invest. Dermatol. 131: 329-337.
49. Agero, A. L., S. W. Dusza, C. Benvenuto-Andrade, K. J. Busam, P. Myskowski, and A. C. Halpern. 2006. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J. Am. Acad. Dermatol. 55: 657-670.
50. Hu, J. C., P. Sadeghi, L. C. Pinter-Brown, S. Yashar, and M. W. Chiu. 2007. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J. Am. Acad. Dermatol. 56: 317-326.
51. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
52. Lee, Y. K., H. Turner, C. L. Maynard, J. R. Oliver, D. Chen, C. O. Elson, and C. T. Weaver. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107.
53. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
54. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
55. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
56. Hu, W., T. D. Troutman, R. Edukulla, and C. Pasare. 2011. Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. Immunity 35: 1010-1022.
57. Fedenko, E. S., O. G. Elisyutina, T. M. Filimonova, M. N. Boldyreva, O. V. Burmenskaya, O. Y. Rebrova, A. A. Yarilin, and R. M. Khaitov. 2011. Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals. Self Nonself 2: 120-124.
58. Navarini, A. A., L. E. French, and G. F. Hofbauer. 2011. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J. Allergy Clin. Immunol. 128: 1128-1130.